Eyenovia (EYEN) News Today → One trade. One ticker. One week. (From Wealthpin Pro) (Ad) Free EYEN Stock Alerts $0.58 +0.04 (+7.36%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineEyenovia Provides Clinical and Scientific Update on FDA-Approved Products Mydcombi™ and Clobetasol Propionate Ophthalmic Suspensionglobenewswire.com - April 25 at 7:00 AMEyenovia (EYEN) Price Target Decreased by 24.29% to 7.21msn.com - April 17 at 11:16 AMEyenovia explores strategic alternatives amid new product developmentsinvesting.com - April 10 at 2:39 PMEyenovia Shares Fall More Than 14% After Company Says It Is Exploring Salemarketwatch.com - April 8 at 6:07 PMEyenovia Explores Options, Including Potential Salemarketwatch.com - April 8 at 7:59 AMEyenovia Announces Updated Strategy and Corporate Priorities to Focus on Shareholder Value Generation and Immediate Commercial Opportunitiesglobenewswire.com - April 8 at 7:00 AMEyenovia Increuters.com - April 5 at 10:55 AMLenz Therapeutics’ Eye Drop Helps Improve Vision in Late-Stage Studymsn.com - April 4 at 12:38 AMEyenovia to Feature its Suite of Commercial Products and the Optejet Dispenser at Upcoming National Eyecare Meetingsglobenewswire.com - April 3 at 7:00 AMStuart M. Grant Acquires 100,000 Shares of Eyenovia, Inc. (NASDAQ:EYEN) Stockinsidertrades.com - March 30 at 5:56 AMBrokers Set Expectations for Eyenovia, Inc.'s Q2 2024 Earnings (NASDAQ:EYEN)marketbeat.com - March 22 at 7:50 AMEyenovia, Inc. (NASDAQ:EYEN) Major Shareholder Acquires $61,500.00 in Stockinsidertrades.com - March 21 at 10:32 AMInsider Buying: Eyenovia, Inc. (NASDAQ:EYEN) Major Shareholder Purchases 50,000 Shares of Stockmarketbeat.com - March 20 at 7:54 PMEyenovia, Inc. (EYEN) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 20 at 7:32 PMEyenovia, Inc. (NASDAQ:EYEN) Short Interest Updatemarketbeat.com - March 19 at 8:59 PMEyenovia, Inc.: Eyenovia Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Updatefinanznachrichten.de - March 19 at 1:07 PMEyenovia’s Strategic Commercial Synergy and Growth Potential Reinforce Buy Ratingmarkets.businessinsider.com - March 19 at 1:07 PMEyenovia, Inc. (NASDAQ:EYEN) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 19 at 1:07 PMEyenovia (NASDAQ:EYEN) Issues Quarterly Earnings Results, Beats Expectations By $0.01 EPSmarketbeat.com - March 19 at 9:12 AMEyenovia (NASDAQ:EYEN) Earns Buy Rating from HC Wainwrightmarketbeat.com - March 19 at 8:34 AMQ4 2023 Eyenovia Inc Earnings Callfinance.yahoo.com - March 19 at 8:06 AMRecap: Eyenovia Q4 Earningsbenzinga.com - March 18 at 10:05 PMEYEN Stock Earnings: Eyenovia Misses EPS, Misses Revenue for Q4 2023investorplace.com - March 18 at 10:00 PMEyenovia Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Updatemarkets.businessinsider.com - March 18 at 5:03 PMEyenovia Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Updateglobenewswire.com - March 18 at 4:05 PMEyenovia Q4 2023 Earnings Previewmsn.com - March 17 at 7:43 PMEyenovia (EYEN) Scheduled to Post Quarterly Earnings on Mondaymarketbeat.com - March 17 at 1:23 AMNovaBay Pharmaceuticals and Eyenovia to Co-Promote Prescription Ophthalmic Products to U.S. Eyecare Professionalsglobenewswire.com - March 13 at 7:00 AMEyenovia (EYEN) to Release Quarterly Earnings on Mondaymarketbeat.com - March 12 at 9:59 AMInsider Buying: Eyenovia, Inc. (NASDAQ:EYEN) Major Shareholder Purchases 10,717 Shares of Stockinsidertrades.com - March 12 at 5:37 AMEyenovia, Inc. (NASDAQ:EYEN) Major Shareholder Purchases $16,932.86 in Stockmarketbeat.com - March 11 at 10:23 AMEyenovia to Report Fourth Quarter 2023 Results and Provide Business Update on Monday, March 18thmarkets.businessinsider.com - March 11 at 8:19 AMEyenovia to Report Fourth Quarter 2023 Results and Provide Business Update on Monday, March 18thglobenewswire.com - March 11 at 7:00 AMFY2025 Earnings Forecast for Eyenovia, Inc. Issued By William Blair (NASDAQ:EYEN)marketbeat.com - March 7 at 7:53 AMEyenovia, Formosa Gets FDA Approval For Clobetasol Propionate Ophthalmic Eye Dropsmarkets.businessinsider.com - March 6 at 7:43 PMEyenovia’s Strategic Expansion: Dual Product Offering Enhances Market Positionmarkets.businessinsider.com - March 6 at 7:43 PMEyenovia falls despite FDA nod for pain therapymsn.com - March 6 at 7:43 PMBeyond Cataract Surgery: Analyst Highlights Broader Market Potential For Eyenovia/Formosa's Steroid For Post-Eye Surgery Pain, Inflammationfinance.yahoo.com - March 6 at 7:43 PMHC Wainwright Reaffirms "Buy" Rating for Eyenovia (NASDAQ:EYEN)marketbeat.com - March 6 at 8:44 AMEyenovia Congratulates Formosa Pharmaceuticals on FDA Approval of Clobetasol Propionate Ophthalmic Suspension 0.05% for the Treatment of Post-operative Inflammation and Pain Following Ocular Surgeryglobenewswire.com - March 5 at 8:00 AMUS FDA approves Eyenovia's eye drug, Formosa Pharma saysreuters.com - March 4 at 10:46 PMUPDATE 2-US FDA approves Eyenovia's eye drug, Formosa Pharma saysfinance.yahoo.com - March 4 at 10:46 PMArmistice Capital LLC Makes New Investment in Eyenovia, Inc. (NASDAQ:EYEN)marketbeat.com - March 3 at 10:50 AMretail investors who own 56% along with institutions invested in Eyenovia, Inc. (NASDAQ:EYEN) saw increase in their holdings value last weekfinance.yahoo.com - March 1 at 8:34 AMUpcoming FDA decision: Eyenovia’s (EYEN) APP13007msn.com - February 29 at 3:24 PMEyenovia: Racing Toward The Finish Lineseekingalpha.com - February 26 at 7:25 PMEyenovia Inc EYENmorningstar.com - February 25 at 9:36 AMEquities Analysts Set Expectations for Eyenovia, Inc.'s Q1 2024 Earnings (NASDAQ:EYEN)marketbeat.com - February 16 at 8:32 AMFDA approves Eyenovia manufacturing facility in Redwood Citymsn.com - February 13 at 7:53 PMEyenovia, Inc.: Eyenovia Announces FDA Approval of Redwood City as Commercial Manufacturing Facilityfinanznachrichten.de - February 13 at 9:39 AM Get Eyenovia News Delivered to You Automatically Sign up to receive the latest news and ratings for EYEN and its competitors with MarketBeat's FREE daily newsletter. Email Address $25,000 into $109,616 in two months? (Ad)Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time… Go here to watch the most recent trading workshop video at no charge. EYEN Media Mentions By Week EYEN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EYEN News Sentiment▼0.000.43▲Average Medical News Sentiment EYEN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EYEN Articles This Week▼02▲EYEN Articles Average Week Get Eyenovia News Delivered to You Automatically Sign up to receive the latest news and ratings for EYEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ACXP News Today ALRN News Today SLGL News Today FBRX News Today ENLV News Today UBX News Today APM News Today SNSE News Today VIRX News Today DRRX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EYEN) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeGreat Crypto BullWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eyenovia, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
